Callan Family Office’s Microchip Technology MCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.71M Sell
106,442
-1,866
-2% -$166K 0.19% 101
2026
Q1
$7M Sell
108,308
-9,836
-8% -$707K 0.16% 136
2025
Q4
$7.53M Buy
118,144
+15,420
+15% +$951K 0.16% 121
2025
Q3
$6.6M Sell
102,724
-8,104
-7% -$549K 0.21% 108
2025
Q2
$7.8M Buy
110,828
+76,852
+226% +$4.22M 0.25% 87
2025
Q1
$1.64M Sell
33,976
-24,157
-42% -$1.35M 0.12% 150
2024
Q4
$3.33M Buy
58,133
+54,093
+1,339% +$3.72M 0.21% 93
2024
Q3
$324K Buy
4,040
+1,072
+36% +$88.5K 0.05% 134
2024
Q2
$272K Buy
+2,968
New +$272K 0.05% 127
2023
Q2
– Sell
-14,563
Closed -$1.22M – 137
2023
Q1
$1.22M Buy
+14,563
New +$1.16M 0.3% 49

Other funds holding MCHP

Callan Family Office's MCHP Position: Q2 2026 in Review

Callan Family Office reduced its Microchip Technology (MCHP) stake by 1.7% in Q2 2026, selling an estimated $166K and leaving 106,442 shares worth $9.71M. The position accounts for 0.19% of the portfolio, ranked #101.

Callan Family Office first reported a position in MCHP in Q1 2023 and has held it in 10 quarters since. 1,288 funds tracked by Wall St. Rank hold MCHP as of Q2 2026.

  • Callan Family Office held 106,442 shares of Microchip Technology worth $9.71M as of Q2 2026.
  • Callan Family Office sold 1,866 Microchip Technology shares in Q2 2026, an estimated $166K.
  • Microchip Technology made up 0.19% of Callan Family Office's portfolio in Q2 2026, its #101 holding.
  • Callan Family Office first reported a position in Microchip Technology in Q1 2023 and has held it in 10 quarters since.
  • 1,288 funds tracked by Wall St. Rank held Microchip Technology as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.